BBP Virtus LifeSci Biotech Products ETF
BBP Fund Description
BBP tracks an index of US-listed biotechnology companies considered to be in the “product stage” by the index provider.
BBP Factset Analytics Insight
BBP offers a different approach to biotech investing by handpicking firms whose lead drugs are on its product stage or those firms that have attained FDA approval for their leading drug. Stocks must earn a majority of their revenue from the research and development and/or marketing and sale of novel drugs or other therapeutics used in the treatment of human diseases. The fund is offered by BioShares alongside launched a sister fund, BBC, which targets biotech firms in the clinical trial stage. The index is reconstituted on a semi-annual basis.
BBP Summary Data
BBP Portfolio Data
BBP Index Data
BBP Portfolio Management
BBP Tax Exposures
BBP Fund Structure
BBP Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of BBP. BBP is rated a 4 out of 5.
BBP Sector/Industry Breakdown
BBP Top 10 Holdings[View All]
BBP Economic Development
BBP Performance Statistics
BBP Benchmark Comparison Summary
BBP Benchmark Comparison Market Cap Size